Skip to main content
. 2021 Dec 17;5(24):5536–5545. doi: 10.1182/bloodadvances.2021005566

Table 2.

Summary of grade 3 or higher treatment-emergent adverse events according to CTCAE version 5.0

AEs regardless of attribution Grade 3 Grade 4
Acute kidney injury 1 (5)
Alanine aminotransferase increased 3 (14)
Anorexia 1 (5)
Aspartate aminotransferase increased 2 (9)
Bone pain 1 (5)
Depression 1 (5)
Diarrhea 3 (14)
Disease progression 2 (9)
Esophageal pain 1 (5)
Fatigue 1 (5)
Febrile neutropenia 2 (9)
Hematuria 1 (5)
Hyperglycemia 1 (5)
Mucositis oral 2 (9)
Neutrophil count decreased 2 (9) 4 (18)
Platelet count decreased 6 (27) 3 (14)
Pleural effusion 1 (5)
Rash maculo-papular 4 (18)
Sepsis 1 (5)
Vascular access complication 2 (9)
White blood cell decreased 1 (5) 4 (18)

Data are expressed as N (%). CTCAE, Common Toxicity Criteria for Adverse Events.